-
1
-
-
0025763425
-
The clinical use of colony stimulating factors
-
Moore MAS. The clinical use of colony stimulating factors. Ann Rev Immunol 1991;9:159-83.
-
(1991)
Ann Rev Immunol
, vol.9
, pp. 159-183
-
-
Moore, M.A.S.1
-
2
-
-
0028556418
-
The clinical utility of granulocyte colony-stimulating factor: Early achievement and future promise
-
Morstyn G, Foote M, Perkins D, Vincent M. The clinical utility of granulocyte colony-stimulating factor: early achievement and future promise. Stem Cells 1994;12 (Suppl. 1):213-27.
-
(1994)
Stem Cells
, vol.12
, Issue.SUPPL. 1
, pp. 213-227
-
-
Morstyn, G.1
Foote, M.2
Perkins, D.3
Vincent, M.4
-
3
-
-
0030844757
-
The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation
-
Tabbara IA, Ghazal CD, Ghazal HH. The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation. Cancer Invest 1997;15:353-7.
-
(1997)
Cancer Invest
, vol.15
, pp. 353-357
-
-
Tabbara, I.A.1
Ghazal, C.D.2
Ghazal, H.H.3
-
4
-
-
0028063675
-
Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies
-
Stahel RA, Jost LM, Cerny T, Pichert G, Honegger H, Tobler A et al. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol 1994;12:1931-8.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1931-1938
-
-
Stahel, R.A.1
Jost, L.M.2
Cerny, T.3
Pichert, G.4
Honegger, H.5
Tobler, A.6
-
5
-
-
0029008334
-
Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial
-
Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. J Clin Oncol 1995;13:1323-7.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1323-1327
-
-
Klumpp, T.R.1
Mangan, K.F.2
Goldberg, S.L.3
Pearlman, E.S.4
Macdonald, J.S.5
-
6
-
-
0031017172
-
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit
-
McQuaker IG, Hunter AE, Pacey S, Haynes AP, Iqbal A, Russell NH. Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol 1997;15:451-7.
-
(1997)
J Clin Oncol
, vol.15
, pp. 451-457
-
-
McQuaker, I.G.1
Hunter, A.E.2
Pacey, S.3
Haynes, A.P.4
Iqbal, A.5
Russell, N.H.6
-
7
-
-
0028133039
-
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation
-
Schriber JR, Chao NJ, Long GD, Negrin RS, Tierney DK, Kusnierz-Glaz C et al. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood 1994;84:1680-4.
-
(1994)
Blood
, vol.84
, pp. 1680-1684
-
-
Schriber, J.R.1
Chao, N.J.2
Long, G.D.3
Negrin, R.S.4
Tierney, D.K.5
Kusnierz-Glaz, C.6
-
8
-
-
0032532624
-
Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation
-
Lee SJ, Weller E, Alyea EP, Ritz J, Soiffer RJ. Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation. Blood 1998;92:2725-9.
-
(1998)
Blood
, vol.92
, pp. 2725-2729
-
-
Lee, S.J.1
Weller, E.2
Alyea, E.P.3
Ritz, J.4
Soiffer, R.J.5
-
9
-
-
1442265964
-
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
-
Ringden O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2004;22:416-23.
-
(2004)
J Clin Oncol
, vol.22
, pp. 416-423
-
-
Ringden, O.1
Labopin, M.2
Gorin, N.C.3
Le Blanc, K.4
Rocha, V.5
Gluckman, E.6
-
10
-
-
0025618868
-
Granulocyte colony-stimulating factor
-
Nicola NA. Granulocyte colony-stimulating factor. Immunol Series 1990;49:77-109.
-
(1990)
Immunol Series
, vol.49
, pp. 77-109
-
-
Nicola, N.A.1
-
11
-
-
0025885415
-
Granulocyte colony-stimulating factor and its receptor
-
Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-808.
-
(1991)
Blood
, vol.78
, pp. 2791-2808
-
-
Demetri, G.D.1
Griffin, J.D.2
-
12
-
-
0027281568
-
Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo
-
Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 1993;84:574-80.
-
(1993)
Br J Haematol
, vol.84
, pp. 574-580
-
-
Ohsaka, A.1
Saionji, K.2
Sato, N.3
Mori, T.4
Ishimoto, K.5
Inamatsu, T.6
-
13
-
-
0024457849
-
Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence
-
Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989;74:2144-9.
-
(1989)
Blood
, vol.74
, pp. 2144-2149
-
-
Yuo, A.1
Kitagawa, S.2
Ohsaka, A.3
Ohta, M.4
Miyazono, K.5
Okabe, T.6
-
14
-
-
0027476531
-
Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells
-
Kerst JM, van de Winkel JG, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP et al. Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 1993;81:1457-64.
-
(1993)
Blood
, vol.81
, pp. 1457-1464
-
-
Kerst, J.M.1
Van De Winkel, J.G.2
Evans, A.H.3
De Haas, M.4
Slaper-Cortenbach, I.C.5
De Wit, T.P.6
-
15
-
-
0027482755
-
Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells
-
Kerst JM, de Haas M, van de Schoot CE, Slaper-Cortenbach IC, von Kleijer M, von dem Borne AE et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
-
(1993)
Blood
, vol.82
, pp. 3265-3272
-
-
Kerst, J.M.1
De Haas, M.2
Van De Schoot, C.E.3
Slaper-Cortenbach, I.C.4
Von Kleijer, M.5
Von Dem Borne, A.E.6
-
16
-
-
0028131845
-
Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils
-
de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994;84:3885-94.
-
(1994)
Blood
, vol.84
, pp. 3885-3894
-
-
De Haas, M.1
Kerst, J.M.2
Van Der Schoot, C.E.3
Calafat, J.4
Hack, C.E.5
Nuijens, J.H.6
-
17
-
-
0028946236
-
Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes
-
Ohsaka A, Saionji K, Kuwaki T, Takeshima T, Igari J. Granulocyte colony-stimulating factor administration modulates the surface expression of effector cell molecules on human monocytes. Br J Haematol 1995;89:465-72.
-
(1995)
Br J Haematol
, vol.89
, pp. 465-472
-
-
Ohsaka, A.1
Saionji, K.2
Kuwaki, T.3
Takeshima, T.4
Igari, J.5
-
18
-
-
0031982524
-
Granulocyte colony-stimulating factor administration increases serum concentrations of soluble selectins
-
Ohsaka A, Saionji K, Igari J. Granulocyte colony-stimulating factor administration increases serum concentrations of soluble selectins. Br J Haematol 1998;100:66-9.
-
(1998)
Br J Haematol
, vol.100
, pp. 66-69
-
-
Ohsaka, A.1
Saionji, K.2
Igari, J.3
-
19
-
-
0028927105
-
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers
-
Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, Stevens P et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995;85:2482-9.
-
(1995)
Blood
, vol.85
, pp. 2482-2489
-
-
Hartung, T.1
Docke, W.D.2
Gantner, F.3
Krieger, G.4
Sauer, A.5
Stevens, P.6
-
20
-
-
0030056892
-
Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men
-
Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 1996;87:900-5.
-
(1996)
Blood
, vol.87
, pp. 900-905
-
-
Pollmächer, T.1
Korth, C.2
Mullington, J.3
Schreiber, W.4
Sauer, J.5
Vedder, H.6
-
21
-
-
0030874199
-
Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans
-
Pajkrt D, Manten A, vanderPoll T, Tiel-van Buul MMC, Jansen J, Wouterten CJ et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997;90:1415-24.
-
(1997)
Blood
, vol.90
, pp. 1415-1424
-
-
Pajkrt, D.1
Manten, A.2
VanderPoll, T.3
Tiel-Van Buul, M.M.C.4
Jansen, J.5
Wouterten, C.J.6
-
22
-
-
0030822084
-
Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): Possible role of lactoferrin and interleukin-1 receptor antagonist
-
Rutella S, Rumi C, Testa U, Sica S, Teofili L, Martucci R et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant 1997;20:355-64.
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 355-364
-
-
Rutella, S.1
Rumi, C.2
Testa, U.3
Sica, S.4
Teofili, L.5
Martucci, R.6
-
23
-
-
0029147465
-
Interleukin-1 receptor antagonist
-
Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995;15:77-105.
-
(1995)
Crit Rev Immunol
, vol.15
, pp. 77-105
-
-
Lennard, A.C.1
-
25
-
-
0031831906
-
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
-
Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-99.
-
(1998)
Int Rev Immunol
, vol.16
, pp. 457-499
-
-
Dinarello, C.A.1
-
26
-
-
0028018567
-
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial
-
The IL-1ra Sepsis Syndrome Study Group
-
Fisher CJ, Slotman GJ, Opal SM, Fribble JP, Bone RC, Emmanuel G et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1ra Sepsis Syndrome Study Group. Crit Care Med 1994;22:12-21.
-
(1994)
Crit Care Med
, vol.22
, pp. 12-21
-
-
Fisher, C.J.1
Slotman, G.J.2
Opal, S.M.3
Fribble, J.P.4
Bone, R.C.5
Emmanuel, G.6
-
28
-
-
0037111657
-
Interleukin-1 blockade does not prevent acute graft versus host disease. Results of a randomized, double blind, placebo-controlled trial of interleukin 1 receptor antagonist in allogeneic bone marrow Transplantation
-
Antin JH, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee SJ et al. Interleukin-1 blockade does not prevent acute graft versus host disease. Results of a randomized, double blind, placebo-controlled trial of interleukin 1 receptor antagonist in allogeneic bone marrow Transplantation. Blood 2002;100:3479-82.
-
(2002)
Blood
, vol.100
, pp. 3479-3482
-
-
Antin, J.H.1
Weisdorf, D.2
Neuberg, D.3
Nicklow, R.4
Clouthier, S.5
Lee, S.J.6
-
29
-
-
0028067822
-
Regulation of cytokine expression by interferon-α in human bone marrow stromal cell: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist
-
Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C. Regulation of cytokine expression by interferon-α in human bone marrow stromal cell: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 1994;84:4142-50.
-
(1994)
Blood
, vol.84
, pp. 4142-4150
-
-
Aman, M.J.1
Keller, U.2
Derigs, G.3
Mohamadzadeh, M.4
Huber, C.5
Peschel, C.6
-
30
-
-
0028073119
-
Aplastic anemia: Analysis of stromal cell function in long-term marrow cultures
-
Holmberg LA, Seidel K, Leisenring W, Torok-Storb B. Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 1994;84:3685-90.
-
(1994)
Blood
, vol.84
, pp. 3685-3690
-
-
Holmberg, L.A.1
Seidel, K.2
Leisenring, W.3
Torok-Storb, B.4
-
31
-
-
0028947458
-
Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity
-
Chudgar UH, Rundus CH, Peterson VM. Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity. Blood 1995;85:2393-401.
-
(1995)
Blood
, vol.85
, pp. 2393-2401
-
-
Chudgar, U.H.1
Rundus, C.H.2
Peterson, V.M.3
-
32
-
-
0026330925
-
Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells
-
Rimbaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR et al. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991;78:3248-53.
-
(1991)
Blood
, vol.78
, pp. 3248-3253
-
-
Rimbaldi, A.1
Torcia, M.2
Bettoni, S.3
Vannier, E.4
Barbui, T.5
Shaw, A.R.6
-
33
-
-
0026732573
-
Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors
-
Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D et al. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 1992;79:1838-945.
-
(1992)
Blood
, vol.79
, pp. 1838-1945
-
-
Estrov, Z.1
Kurzrock, R.2
Estey, E.3
Wetzler, M.4
Ferrajoli, A.5
Harris, D.6
-
34
-
-
0029998207
-
Interleukin 1 receptor antagonsit (IL1RA) in acute leukemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is part of the acute phase reaction in patients with chemotherapy-induced leucopenia
-
Bruserod O, Aasen I, Akselsen PE, Bergheim J, Rasmussen G, Nesthus I. Interleukin 1 receptor antagonsit (IL1RA) in acute leukemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is part of the acute phase reaction in patients with chemotherapy-induced leucopenia. Eur J Haematol 1996;57:87-95.
-
(1996)
Eur J Haematol
, vol.57
, pp. 87-95
-
-
Bruserod, O.1
Aasen, I.2
Akselsen, P.E.3
Bergheim, J.4
Rasmussen, G.5
Nesthus, I.6
-
35
-
-
0025946285
-
Suppression of chronic myeloid leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: A novel application for inhibitors of IL-1 activity
-
Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D et al. Suppression of chronic myeloid leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood 1991;78:1476-86.
-
(1991)
Blood
, vol.78
, pp. 1476-1486
-
-
Estrov, Z.1
Kurzrock, R.2
Wetzler, M.3
Kantarjian, H.4
Blake, M.5
Harris, D.6
-
36
-
-
0030824872
-
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: Excellent feasibility and low incidence of treatment-related toxicity
-
Bertz H, Potthoff K, Mertelsmann R, Finke J. Busulfan/ cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity. Bone Marrow Transplant 1997;19:1169-73.
-
(1997)
Bone Marrow Transplant
, vol.19
, pp. 1169-1173
-
-
Bertz, H.1
Potthoff, K.2
Mertelsmann, R.3
Finke, J.4
-
37
-
-
0032969258
-
Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors
-
Berger C, Bertz H, Schmoor C, Behringer D, Potthoff K, Mertelsmann R et al. Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors. Bone Marrow Transplant 1999;23:983-90.
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 983-990
-
-
Berger, C.1
Bertz, H.2
Schmoor, C.3
Behringer, D.4
Potthoff, K.5
Mertelsmann, R.6
-
38
-
-
0028926373
-
Calculating correlation coefficients with repeated observations: Part 1 - Correlation within subjects
-
Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 1 - correlation within subjects. Br Med J 1995;310:446.
-
(1995)
Br Med J
, vol.310
, pp. 446
-
-
Bland, J.M.1
Altman, D.G.2
-
39
-
-
0028927937
-
Calculating correlation coefficients with repeated observations: Part 2 - Correlation between subjects
-
Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 2 - correlation between subjects. Br Med J 1995;310:633.
-
(1995)
Br Med J
, vol.310
, pp. 633
-
-
Bland, J.M.1
Altman, D.G.2
-
40
-
-
0030961241
-
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein
-
Gabay C, Smith MF, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 1997;99:2930-40.
-
(1997)
J Clin Invest
, vol.99
, pp. 2930-2940
-
-
Gabay, C.1
Smith, M.F.2
Eidlen, D.3
Arend, W.P.4
-
41
-
-
0028172866
-
Altered levels of interleukin-1b and interleukin-1 receptor antagonist in chronic myelogenous leukemia: Clinical and prognostic correlates
-
Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink M et al. Altered levels of interleukin-1b and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood 1994;84:3142-7.
-
(1994)
Blood
, vol.84
, pp. 3142-3147
-
-
Wetzler, M.1
Kurzrock, R.2
Estrov, Z.3
Kantarjian, H.4
Gisslinger, H.5
Underbrink, M.6
-
42
-
-
0027518593
-
Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphnuclear cells
-
Re F, Mengozzi F, Muzio M, Dinarello CA, Mantovani A, Colotta F. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphnuclear cells. Eur J Immunol 1993;23:570-3.
-
(1993)
Eur J Immunol
, vol.23
, pp. 570-573
-
-
Re, F.1
Mengozzi, F.2
Muzio, M.3
Dinarello, C.A.4
Mantovani, A.5
Colotta, F.6
-
43
-
-
0028218242
-
Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta
-
Malyak M, Smith MF, Abel AA, Arend WP. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol 1994;14:20-30.
-
(1994)
J Clin Immunol
, vol.14
, pp. 20-30
-
-
Malyak, M.1
Smith, M.F.2
Abel, A.A.3
Arend, W.P.4
-
44
-
-
0026717870
-
Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha
-
McColl SR, Paquin R, Menard C, Beaulieu AD. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 1992;176:593-8.
-
(1992)
J Exp Med
, vol.176
, pp. 593-598
-
-
McColl, S.R.1
Paquin, R.2
Menard, C.3
Beaulieu, A.D.4
-
45
-
-
0030614515
-
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: Increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy
-
Schwaighofer H, Oberhuber G, Hebart H, Einsele H, Herold M, Nachbaur D et al. Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy. Transplantation 1997;63:52-66.
-
(1997)
Transplantation
, vol.63
, pp. 52-66
-
-
Schwaighofer, H.1
Oberhuber, G.2
Hebart, H.3
Einsele, H.4
Herold, M.5
Nachbaur, D.6
-
46
-
-
0032532205
-
Serum cytokine levels after HLA-identical bone marrow transplantation
-
Liem LM, vanHouwelingen HC, Goulmy E. Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 1998;66:863-71.
-
(1998)
Transplantation
, vol.66
, pp. 863-871
-
-
Liem, L.M.1
VanHouwelingen, H.C.2
Goulmy, E.3
-
47
-
-
0029768091
-
Functions of interleukin 1 receptor antagonist in gene knock out and overproducing mice
-
Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knock out and overproducing mice. Proc Natl Acad Sci USA 1996;93:11008-13.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 11008-11013
-
-
Hirsch, E.1
Irikura, V.M.2
Paul, S.M.3
Hirsh, D.4
-
48
-
-
0029981668
-
In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in mice
-
Jovcic G, Ivanovic Z, Biljanovic-Paunovic L, Bugarski D, Stosic-Grujicic S, Milenkovic P. In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in mice. Eur Cytokine Network 1996;7:71-4.
-
(1996)
Eur Cytokine Network
, vol.7
, pp. 71-74
-
-
Jovcic, G.1
Ivanovic, Z.2
Biljanovic-Paunovic, L.3
Bugarski, D.4
Stosic-Grujicic, S.5
Milenkovic, P.6
-
50
-
-
0023600013
-
Synergy of interleukin-1 and granulocyte colony-stimulating factor, in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice
-
Moore MA, Warren DJ. Synergy of interleukin-1 and granulocyte colony-stimulating factor, in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci 1987;84:7134-8.
-
(1987)
Proc Natl Acad Sci
, vol.84
, pp. 7134-7138
-
-
Moore, M.A.1
Warren, D.J.2
-
51
-
-
0023905482
-
Protective, restorative, and therapeutic properties of recombinant human TT-1 in rodent models
-
Castelli MP, Black PL, Schneider M, Pennington R, Abe F, Talmadge JE. Protective, restorative, and therapeutic properties of recombinant human TT-1 in rodent models. J Immunol 1988;140:3830-7.
-
(1988)
J Immunol
, vol.140
, pp. 3830-3837
-
-
Castelli, M.P.1
Black, P.L.2
Schneider, M.3
Pennington, R.4
Abe, F.5
Talmadge, J.E.6
-
52
-
-
0025805859
-
In vivo administration of granulocyte colony-stimulating factor (G- CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation
-
Atkinson K, Matias C, Guiffre A, Seymour R, Cooley M, Biggs J et al. In vivo administration of granulocyte colony-stimulating factor (G- CSF), granulocyte-macrophage CSF, interleukin-1 (IL-1), and IL-4, alone and in combination, after allogeneic murine hematopoietic stem cell transplantation. Blood 1991;77:1376-82.
-
(1991)
Blood
, vol.77
, pp. 1376-1382
-
-
Atkinson, K.1
Matias, C.2
Guiffre, A.3
Seymour, R.4
Cooley, M.5
Biggs, J.6
-
53
-
-
0028178474
-
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia
-
Nemunaitis J, Appelbaum FR, Lilleby K, Buhles WC, Rosenfeld C, Zeigler ZR et al. Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia. Blood 1994;83:3473-9.
-
(1994)
Blood
, vol.83
, pp. 3473-3479
-
-
Nemunaitis, J.1
Appelbaum, F.R.2
Lilleby, K.3
Buhles, W.C.4
Rosenfeld, C.5
Zeigler, Z.R.6
-
54
-
-
0028169280
-
Interleukin-1 alpha administered after autologous transplantation: A phase I/II clinical trial
-
Weisdorf D, Katsanis E, Verfaillie C, Ramsay NK, Haake R, Garrison L et al. Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial. Blood 1994;84:2044-9.
-
(1994)
Blood
, vol.84
, pp. 2044-2049
-
-
Weisdorf, D.1
Katsanis, E.2
Verfaillie, C.3
Ramsay, N.K.4
Haake, R.5
Garrison, L.6
-
55
-
-
0031045211
-
A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation
-
Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P et al. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant 1997;19:315-22.
-
(1997)
Bone Marrow Transplant
, vol.19
, pp. 315-322
-
-
Elkordy, M.1
Crump, M.2
Vredenburgh, J.J.3
Petros, W.P.4
Hussein, A.5
Rubin, P.6
-
56
-
-
0030611646
-
The pattern of interleukin-1β (IL-1β) and its modulating agent IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections
-
van Deuren M, van der Ven-Jongekrijg J, Vannier E, van Dalen R, Pesman G, Bartelink AKM et al. The pattern of interleukin-1β (IL-1β) and its modulating agent IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 1997;90:1101-8.
-
(1997)
Blood
, vol.90
, pp. 1101-1108
-
-
Van Deuren, M.1
Van Der Ven-Jongekrijg, J.2
Vannier, E.3
Van Dalen, R.4
Pesman, G.5
Bartelink, A.K.M.6
-
57
-
-
0025786074
-
Production of interleukin 1 receptor antagonist during experimental endotoxaemia
-
Granovitz EV, Santos AA, Poutsiaka D, Cannon JG, Wilmore DW, Wolff SM et al. Production of interleukin 1 receptor antagonist during experimental endotoxaemia. Lancet 1991;338:1423-6.
-
(1991)
Lancet
, vol.338
, pp. 1423-1426
-
-
Granovitz, E.V.1
Santos, A.A.2
Poutsiaka, D.3
Cannon, J.G.4
Wilmore, D.W.5
Wolff, S.M.6
-
58
-
-
0033556353
-
Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis
-
Weiss M, Moldawer LL, Schneider EM. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis. Blood 1999;93:425-39.
-
(1999)
Blood
, vol.93
, pp. 425-439
-
-
Weiss, M.1
Moldawer, L.L.2
Schneider, E.M.3
|